Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Investigation and Management of Prostate Cancer
Prostate Cancer What a GP Needs to Know
A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology Tata.
Clinically localized prostate cancer: Prostatectomy David D. Thiel, MD Mayo Clinic Florida Department of Urology.
The Challenge of Prostate Cancer Genitourinary Cancer Center at M. D. Anderson PERSONALIZED MEDICINE.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
Prevention Strategies Rajesh G. Laungani MD Director, Robotic Urology Chairman, Prostate Cancer Center Saint Joseph’s Hospital, Atlanta.
Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Prostate Cancer Treatments By: Ishan Parikh. Symptoms Be on the look out for… “stop-and-go” flow of urine Sudden urges to urinate Frequent urination (esp.
Steven Joniau Filip Ameye
Prostate Radiotherapy A-Z
Everything you need to know about Prostate Radiotherapy During the talk or at end send QUESTIONS: Rob.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B. Garber, MD, FACS Clinical Associate Professor Drexel University College of Medicine.
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
Akbar Ashrafi Surgical Students Society of Melbourne September 2010.
Modern Management of Prostate Cancer With Active Surveillance PROSTATE CANCER SYMPOSIUM NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE SEPTEMBER 10,
Prostate Cancer James B. Benton,M.D.. Prostate Cancer Significant of the clinical problem Early detection/screening Prevention/Management.
Conclusions HDR brachytherapy boost combined with moderate dose external beam irradiation resulted in a very high local control rate and few recurrences.
Ademola Popoola,BUHARI TAJUDEEN,Fidelis Ushie,Hamid Olanipekun. Department of Surgery University of Ilorin Teaching Hospital,Ilorin. Multiple Primary Cancers.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
Mark L. Merlin, M.D. Radiotherapy Clinics of Georgia 7/14/2010 The Role of Radiation Therapy in the Management of Prostate Cancer.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Poster Title ABSTRACT #59 Cell cycle progression genes differentiate indolent from aggressive prostate cancer. Steven Stone 1 Jack Cuzick 2, Julia Reid.
Prostate Cancer Screening Risk Management Ben Inch.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
David Spellberg, MD Naples Urological Associates High Intensity Focused Ultrasound Sonablate ® HIFU A Minimally Invasive Way to Treat Prostate Cancer.
South West Public Health Observatory South West Regional Public Health Group Prostate cancer in England and the South West Sean McPhail 1, Paul Eves 1,
HIFU AND CRYOSURGERY David Spellberg M.D., FACS.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Life after Prostate Cancer and its treatment Mr Sanjeev Pathak Consultant Urological Surgeon and Cancer Lead Doncaster and Bassetlaw NHS Trust 12 th March.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Manit Arya Consultant Urological Surgeon UCLH and PAH Transforming the Pathway in Prostate Cancer.
Cyberknife Therapy for Prostate Cancer David Spellberg M.D., FACS Naples Urology Associates, P.A.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Journal Club August 10, 2012 Ryan M. Zitnay MD. Case 71 y/o male veteran w PMH CAD s/p MI, HTN, HL, constipation Followed by urology for rising PSA x.
Start the Conversation
Radiation therapy for Early Stage Prostate Cancer
Bladder Cancer and Prostatic Cancer
J. Edson PontesM.D. Professor Urologic Oncology WSU/KCI
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
How I talk to my patients about HIFU
2017 USPSTF Draft Recommendations for Prostate Cancer Screening
CONVERSATIONS ON PROSTATE CANCER
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Post Op Positive Seminal Vesicle Case 4: Prostate_4
Prostate Cancer: Highlights from 2006
Apollo Gleneagles Hospitals,
Figure 3 Semantic model of the active surveillance (AS) timeline
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
EARLY AND LATE COMPLICATIONS OF PROSTATE LOW DOSE BRACHYTHERAPY
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Genomic Testing: When and Why
Prostate Cancer Update
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Presentation transcript:

Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary Oncology Genitourinary Oncology Mayo Clinic Florida Mayo Clinic Florida

Incidence 230,000 cases each year 230,000 cases each year 30,000 deaths each year 30,000 deaths each year Indolent Indolent Aggressive disease Aggressive disease Jemal et al 2009 Jemal et al 2009

Biopsy Sextant biopsy Sextant biopsy Template biopsy Template biopsy Importance for diagnosis Importance for diagnosis PSA of 50 and above PSA of 50 and above

Diagnosis PSA PSA Gleason Score Gleason Score Stage Stage Metastasis or not Metastasis or not

Gleason score Microscopic appearance Microscopic appearance 1 well differentiated 1 well differentiated 5 poorly differentiated 5 poorly differentiated Maximum score of each site:5 Maximum score of each site:5 Add score of 2 sites Add score of 2 sites

Treatment Options Radical Prostatectomy Radical Prostatectomy External beam radiation External beam radiation Brachytherapy( interstitial seed implant) Brachytherapy( interstitial seed implant) Combination of external beam radiation and seed implant Combination of external beam radiation and seed implant Observation Observation

Radical prostatectomy Full evaluation of pathology Full evaluation of pathology Risk of anesthesia Risk of anesthesia Impotence Impotence Urinary incontinence Urinary incontinence Morbidity from surgery Morbidity from surgery

External beam radiation Treat more area if there is extracapsular involvement Treat more area if there is extracapsular involvement Gastrointestinal complications Gastrointestinal complications Radiation cystitis Radiation cystitis Radiation proctitis Radiation proctitis Urinary incontinence Urinary incontinence

Brachytherapy Not for everybody Not for everybody Low risk Low risk More radiation cystitis More radiation cystitis Inadequate cure of cancer Inadequate cure of cancer

Observation Scandinavian studies Scandinavian studies Low gleason score :6 and below Low gleason score :6 and below Elderly patients Elderly patients Less than 10 years to live Less than 10 years to live

Options Treatment options are equal based Treatment options are equal based On patients followed On patients followed No randomized clinical trials

Medical team Urologist Urologist Radiation oncologist Radiation oncologist Medical oncologist Medical oncologist Nephrologist Nephrologist Nursing Nursing Physical therapy Physical therapy

Choice Choice The choice is yours !!! The choice is yours !!!

Prostate Cancer You are in charge You are in charge Empower patients Empower patients Educate patients Educate patients Stimulate interest in participation in clinical trials Stimulate interest in participation in clinical trials

Thank You Thank You Questions ? Questions ?